Pathogenesis and Therapeutic Intervention of Alzheimer's Disease

Dear Colleagues,

Alzheimer's Disease (AD) is the most common cause of dementia. Neuronal death occurs via several mechanisms, including oxidative stress, excitotoxicity, energy depletion, inflammation, and apoptosis, particularly in brain regions that are essential for cognitive and memory functions. Although no therapeutic approach has achieved complete success in the treatment of AD, the early detection and management of AD with appropriate drugs is crucial for improving prognosis. An enhanced understanding of the molecular mechanisms that underlie neuronal cell death and glial homeostasis could pave the way for novel therapeutic strategies. Several treatments have progressed to the clinical stage, including acetylcholinesterase inhibitors, nerve growth factors, nonsteroidal anti-inflammatory drugs (NSAIDs), estrogen, and compounds such as antioxidants, neuronal calcium channel blockers, and anti-apoptotic agents. More recently, it has been suggested that the gut microbiome could influence the function of the brain . Additionally, the application of artificial intelligence in the identification of novel AD-related genes has provided new opportunities for research and therapeutic development.

You may choose our Joint Special Issue in Neurology International.

Dr. Chanchal Sharma
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.